Cargando…

Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation

(+)-[(11)C]PHNO, a dopamine D(2/3) receptor agonistic radiotracer, is applied for investigating the dopaminergic system via positron emission tomography (PET). An improved understanding of neuropsychiatric disorders associated with dysfunctions in the dopamine system and the underlying mechanism is...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaff, Sarah, Philippe, Cécile, Nics, Lukas, Berroterán-Infante, Neydher, Pallitsch, Katharina, Rami-Mark, Christina, Weidenauer, Ana, Sauerzopf, Ulrich, Willeit, Matthäus, Mitterhauser, Markus, Hacker, Marcus, Wadsak, Wolfgang, Pichler, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791232/
https://www.ncbi.nlm.nih.gov/pubmed/31656452
http://dx.doi.org/10.1155/2019/4292596
_version_ 1783458946518876160
author Pfaff, Sarah
Philippe, Cécile
Nics, Lukas
Berroterán-Infante, Neydher
Pallitsch, Katharina
Rami-Mark, Christina
Weidenauer, Ana
Sauerzopf, Ulrich
Willeit, Matthäus
Mitterhauser, Markus
Hacker, Marcus
Wadsak, Wolfgang
Pichler, Verena
author_facet Pfaff, Sarah
Philippe, Cécile
Nics, Lukas
Berroterán-Infante, Neydher
Pallitsch, Katharina
Rami-Mark, Christina
Weidenauer, Ana
Sauerzopf, Ulrich
Willeit, Matthäus
Mitterhauser, Markus
Hacker, Marcus
Wadsak, Wolfgang
Pichler, Verena
author_sort Pfaff, Sarah
collection PubMed
description (+)-[(11)C]PHNO, a dopamine D(2/3) receptor agonistic radiotracer, is applied for investigating the dopaminergic system via positron emission tomography (PET). An improved understanding of neuropsychiatric disorders associated with dysfunctions in the dopamine system and the underlying mechanism is a necessity in order to promote the development of new potential therapeutic drugs. In contrast to other broadly applied (11)C-radiopharmaceuticals, the production of this radiotracer requires a challenging four-step radiosynthesis involving harsh reaction conditions and reactants as well as an inert atmosphere. Consequently, the production is prone to errors and troubleshooting after failed radiosyntheses remains time consuming. Hence, we aimed to optimize the radiosynthesis of (+)-[(11)C]PHNO for achieving better activity yields without loss of product quality. Therefore, we synthesized (+)-[(11)C]PHNO and omitted all heating and cooling steps leading to higher activity yields. As a result, radiosynthesis fully conducted at room temperature led to a time-reduced production procedure that saves about 5 min, which is an appreciable decay-prevention of around 15% of the activity yield. Additionally, we established a troubleshooting protocol by investigating reaction intermediates, byproducts, and impurities. Indeed, partial runs enabled the assignment of byproducts to their associated error source. Finally, we were able to generate a decision tree facilitating error detection in (+)-[(11)C]PHNO radiosynthesis.
format Online
Article
Text
id pubmed-6791232
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67912322019-10-25 Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation Pfaff, Sarah Philippe, Cécile Nics, Lukas Berroterán-Infante, Neydher Pallitsch, Katharina Rami-Mark, Christina Weidenauer, Ana Sauerzopf, Ulrich Willeit, Matthäus Mitterhauser, Markus Hacker, Marcus Wadsak, Wolfgang Pichler, Verena Contrast Media Mol Imaging Research Article (+)-[(11)C]PHNO, a dopamine D(2/3) receptor agonistic radiotracer, is applied for investigating the dopaminergic system via positron emission tomography (PET). An improved understanding of neuropsychiatric disorders associated with dysfunctions in the dopamine system and the underlying mechanism is a necessity in order to promote the development of new potential therapeutic drugs. In contrast to other broadly applied (11)C-radiopharmaceuticals, the production of this radiotracer requires a challenging four-step radiosynthesis involving harsh reaction conditions and reactants as well as an inert atmosphere. Consequently, the production is prone to errors and troubleshooting after failed radiosyntheses remains time consuming. Hence, we aimed to optimize the radiosynthesis of (+)-[(11)C]PHNO for achieving better activity yields without loss of product quality. Therefore, we synthesized (+)-[(11)C]PHNO and omitted all heating and cooling steps leading to higher activity yields. As a result, radiosynthesis fully conducted at room temperature led to a time-reduced production procedure that saves about 5 min, which is an appreciable decay-prevention of around 15% of the activity yield. Additionally, we established a troubleshooting protocol by investigating reaction intermediates, byproducts, and impurities. Indeed, partial runs enabled the assignment of byproducts to their associated error source. Finally, we were able to generate a decision tree facilitating error detection in (+)-[(11)C]PHNO radiosynthesis. Hindawi 2019-09-30 /pmc/articles/PMC6791232/ /pubmed/31656452 http://dx.doi.org/10.1155/2019/4292596 Text en Copyright © 2019 Sarah Pfaff et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pfaff, Sarah
Philippe, Cécile
Nics, Lukas
Berroterán-Infante, Neydher
Pallitsch, Katharina
Rami-Mark, Christina
Weidenauer, Ana
Sauerzopf, Ulrich
Willeit, Matthäus
Mitterhauser, Markus
Hacker, Marcus
Wadsak, Wolfgang
Pichler, Verena
Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title_full Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title_fullStr Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title_full_unstemmed Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title_short Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
title_sort toward the optimization of (+)-[(11)c]phno synthesis: time reduction and process validation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791232/
https://www.ncbi.nlm.nih.gov/pubmed/31656452
http://dx.doi.org/10.1155/2019/4292596
work_keys_str_mv AT pfaffsarah towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT philippececile towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT nicslukas towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT berroteraninfanteneydher towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT pallitschkatharina towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT ramimarkchristina towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT weidenauerana towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT sauerzopfulrich towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT willeitmatthaus towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT mitterhausermarkus towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT hackermarcus towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT wadsakwolfgang towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation
AT pichlerverena towardtheoptimizationof11cphnosynthesistimereductionandprocessvalidation